Foster care psychotropic prescribing regulations are complex and insufficient

Area of Science:

• Child and Adolescent Psychiatry
• Public Health Policy
• Health Services Research

Background:

• Foster youth face elevated risks of psychotropic polypharmacy, high dosing, and inadequate monitoring.
• Despite established standards, significant gaps persist in the evidence-based use of psychotropic medications for this population.

Purpose of the Study:

• To analyze state-specific psychotropic medication oversight programs for youth in foster care.
• To examine the distinct approaches and outcomes of these state-level programs.

Main Methods:

• A comprehensive review of state guidelines across all 50 U.S. states and Washington, D.C. was conducted.
• Guidelines were assessed for specificity to foster care and inclusion of criteria such as polypharmacy thresholds, metabolic monitoring, age-based prescribing, and maximum dosages.

Main Results:

• 61% of states have specific psychotropic guidelines for foster care; 18% lack them, and 22% had no guidelines found.
• 38% of foster youth reside in states without psychotropic monitoring requirements.
• 63% of states mandate prior authorization or drug utilization review for multiple psychotropic prescriptions, and 47 states offer age-based prescribing support.

Conclusions:

• Significant variability exists in state approaches to psychotropic medication oversight for foster youth, including age restrictions and monitoring priorities.
• The absence of uniform guidelines and data collection methods creates barriers to optimizing psychotropic prescribing for this vulnerable group.